US Stock Futures Mixed Ahead Of Jobless Claims Data
US stock futures traded mixed in early pre-market trade. Data on weekly jobless claims will be released at 8:30 a.m. ET, while wholesale inventories data for August will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 17 points to 16,886.00, while the Standard & Poor's 500 index futures rose 0.20 points to 1,962.00. Futures for the Nasdaq 100 index gained 3.50 points to 4,034.00.
A Peek Into Global Markets
European markets were mixed today, with the Spanish Ibex Index falling 0.22%, STOXX Europe 600 Index rising 0.21%. German DAX 30 index climbed 0.36%, French CAC 40 Index fell 0.42% and London's FTSE 100 Index dropped 0.04%. France's trade deficit widened to EUR5.78 billion in August, from EUR5.53 billion in July. German exports declined 5.8% on the month in August, while imports dropped 1.3% on the month.
In Asian markets, Japan's Nikkei Stock Average dropped 0.75%, Hong Kong's Hang Seng Index gained 1.17%, China's Shanghai Composite Index jumped 0.28% and India's BSE Sensex climbed 1.49%.
Analysts at Oppenheimer upgraded Apple (NASDAQ: AAPL) from Market Perform to Outperform.
Apple's shares closed at $100.80 yesterday.
- Isis Pharmaceuticals (NASDAQ: ISIS) announced today that it has earned an $18 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP). To read the full news, click here.
- Kratos Defense & Security Solutions (NASDAQ: KTOS) announced today that its Electronic Products Division has received an option award valued at $2.2 million to supply AN/ARA-63 Tactical Instrument Landing Systems (TILS) for both the F/A-18E/F/G and E-2D Naval aircraft. The award to Kratos' Herley Lancaster operation is an extension to a two-year requirements contract issued by the U.S. Navy. To read the full news, click here.
- Endo International (NASDAQ: ENDP) and Auxilium Pharmaceuticals (NASDAQ: AUXL) today announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction. To read the full news, click here.
- Impax Laboratories (NASDAQ: IPXL) today announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, Inc., including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage Therapeutics Inc. (together, the "Companies") for $700 million in cash, subject to certain customary purchase price adjustments. To read the full news, click here.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.